Pere Barba

发表

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

J. Perkins, C. Solano, J. Pidala, 2017, Bone Marrow Transplantation.

Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

J. Pérez-Simón, R. Martino, I. Campos-Varela, 2012, Bone Marrow Transplantation.

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

F. Fernández‐Avilés, R. Martino, R. Duarte, 2015, Bone Marrow Transplantation.

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

J. Briones, S. Brunet, R. Martino, 2017, Bone Marrow Transplantation.

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

C. Solano, F. Sánchez-Guijo, J. Pérez-Simón, 2016, Bone Marrow Transplantation.

Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT

R. Martino, J. Nomdedéu, D. Valcárcel, 2012, Bone Marrow Transplantation.

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience

R. Martino, N. Margall, N. Rabella, 2010, Bone Marrow Transplantation.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

J. Briones, S. Brunet, R. Martino, 2015, Bone Marrow Transplantation.

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.

L. Bento, C. Ferra Coll, O. Salamero, 2024, Bone marrow transplantation.